March 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to ...

Most gardeners have favorite plants they’ve been growing for years and will continue to grow, like fragrant and tasty Big Boy ...

Pakistan Stock Exchange (PSX) on Monday closed almost flat amid uncertainty surrounding the State Bank of Pakistan's (SBP) monetary policy decision later in the day and the outcome of review talks ...

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.

Plus, tips from podiatrists and celebrity stylists on how to wear the style. Claudia Willen is a New York-based Associate Editor at Instyle. She has over five years of experience in writing ...

After hours: March 12 at 4:05:05 PM EDT Loading Chart for DNTH ...